Product NDC: | 47335-330 |
Proprietary Name: | CHLOROTHIAZIDE SODIUM |
Non Proprietary Name: | CHLOROTHIAZIDE SODIUM |
Active Ingredient(s): | 500 mg/18mL & nbsp; CHLOROTHIAZIDE SODIUM |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 47335-330 |
Labeler Name: | Sun Pharma Global FZE |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091546 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110805 |
Package NDC: | 47335-330-40 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (47335-330-40) > 18 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 47335-330-40 |
Proprietary Name | CHLOROTHIAZIDE SODIUM |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (47335-330-40) > 18 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 47335-330 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CHLOROTHIAZIDE SODIUM |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110805 |
Marketing Category Name | ANDA |
Labeler Name | Sun Pharma Global FZE |
Substance Name | CHLOROTHIAZIDE SODIUM |
Strength Number | 500 |
Strength Unit | mg/18mL |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |